由黃文彥醫師主講「Update of Radiotherapy for NPC」。本課程包含一個影片單元,全長 71 分 31 秒。
影片提供 83 個章節索引,可依投影片標題與時間點回顧課程內容。
註冊並登入後即可加入課程。請依序完成課程影片與課後測驗。完整觀看影片並提交測驗後,即可完成課程;測驗不設及格分數門檻,提交後僅顯示總分。
影片章節索引
進入影片與章節導覽 →共 83 個章節。以下可先查看課程內容;登入並加入課程後,可在影片單元點選索引跳轉。
- 1. Update of Radiotherapy for NPC
- 2. Outline
- 3. Update of Radiotherapy for NPC
- 4. Outline
- 5. Introduction to Nasopharyngeal Cancer (NPC)
- 6. Anatomy of the Nasopharynx
- 7. Pathology of NPC
- 8. Slide 6
- 9. TABLE 47.1 FORAMINA OF THE BASE OF THE SKULL AND ASSOCIATED ANATOMIC STRUCTURES
- 10. Local extension of NPC
- 11. Slide 9
- 12. Slide 10
- 13. Local extension of NPC
- 14. Slide 12
- 15. Slide 13
- 16. Local extension of NPC
- 17. Local extension of NPC
- 18. Outline
- 19. Chemoradiotherapy Trials in LA-NPC
- 20. Slide 18
- 21. Chemoradiotherapy Trials in LA-NPC
- 22. Slide 18
- 23. Chemoradiotherapy Trials in LA-NPC
- 24. Slide 20
- 25. Slide 21
- 26. Slide 22
- 27. Chemoradiotherapy Trials in LA-NPC
- 28. Slide 24
- 29. Slide 25
- 30. Current Trials in the Era of Immunotherapy
- 31. Slide 27
- 32. Outline
- 33. Plasma EBV DNA as a Biomarker With Broad Clinical Utility in NPC
- 34. Plasma EBV DNA-Directed Precision Trials and Individualized Treatment
- 35. Slide 31
- 36. Slide 32
- 37. Slide 33
- 38. Slide 34
- 39. Slide 35
- 40. Slide 36
- 41. Slide 37
- 42. Outline
- 43. Slide 39
- 44. Current Dogma of Radiotherapy Target Delineation
- 45. Slide 41
- 46. CTVp_High = GTVp
- 47. CTVp_Mid = CTVp_High + 5mm
- 48. CTVp_Low = CTVp_Mid + 5mm + NP
- 49. CTVp_Mid = CTVp_High + 5mm
- 50. CTVp_Low = CTVp_Mid + 5mm + NP
- 51. GTVp after induction chemotherapy
- 52. For nasopharynx or nasal cavity involvement…
- 53. For muscle involvement…
- 54. For intracranial involvement…
- 55. For bone involvement…
- 56. For paranasal sinus involvement…
- 57. Key question 2: target volume delineation after induction chemotherapy
- 58. Key question 2: target volume delineation after induction chemotherapy
- 59. Key question 3: CTVp_Low delineation based on stepwise local extension patterns of tumour spread
- 60. Key question 2: target volume delineation after induction chemotherapy
- 61. Current Dogma of Radiotherapy Target Delineation
- 62. Case 1: NPCClinical stage, AJCC 8th ed? 9th ed?Treatment?Dose fractionation, critical organ constraint?
- 63. Case 1: NPC
- 64. Case 1: NPC
- 65. Case 1: NPC
- 66. Case 2 Clinical TNM? Treatment?
- 67. Pathology
- 68. Case 2 Clinical TNM? Treatment?
- 69. Case 1: NPC
- 70. Case 1: NPC
- 71. Case 1: NPC
- 72. Case 1: NPCClinical stage, AJCC 8th ed? 9th ed?Treatment?Dose fractionation, critical organ constraint?
- 73. Current Dogma of Radiotherapy Target Delineation
- 74. Case 1: NPCClinical stage, AJCC 8th ed? 9th ed?Treatment?Dose fractionation, critical organ constraint?
- 75. Case 1: NPC
- 76. Case 1: NPCClinical stage, AJCC 8th ed? 9th ed?Treatment?Dose fractionation, critical organ constraint?
- 77. Case 1: NPC
- 78. Case 1: NPC
- 79. Case 1: NPC
- 80. Case 2 Clinical TNM? Treatment?
- 81. Pathology
- 82. Case 2 Tongue cancer
- 83. Slide 63
